Decentralisation in Clinical Trials and Patient Centricity: Benefits and Challenges.
- Published in:
- Pharmaceutical Medicine, 2024, v. 38, n. 2, p. 109, doi. 10.1007/s40290-024-00518-x
- By:
- Publication type:
- Article
Works matching IS 11782595 AND DT 2024 AND VI 38 AND IP 2
Results: 8
1
2
Why Oncology Global Safety Teams Should Develop the Safety Section of the Study's Target Product Profile (TPP).
- Published in:
- Pharmaceutical Medicine, 2024, v. 38, n. 2, p. 97, doi. 10.1007/s40290-024-00516-z
- By:
- Publication type:
- Article
3
Advancing Rheumatology Care Through Machine Learning.
- Published in:
- Pharmaceutical Medicine, 2024, v. 38, n. 2, p. 87, doi. 10.1007/s40290-024-00515-0
- By:
- Publication type:
- Article
4
Female Problems: Women's Health Mustn't be Ghettoized in the Uterus.
- Published in:
- Pharmaceutical Medicine, 2024, v. 38, n. 2, p. 75, doi. 10.1007/s40290-023-00514-7
- By:
- Publication type:
- Article
5
Emergency Approval Mechanisms for Human Vaccines in India.
- Published in:
- Pharmaceutical Medicine, 2024, v. 38, n. 2, p. 121, doi. 10.1007/s40290-023-00513-8
- By:
- Publication type:
- Article
6
Meaningful Within-Patient Change in Subjective Total Sleep Time in Patients with Insomnia Disorder: An Analysis of the Sleep Diary Questionnaire Using Data from Open-Label and Phase III Clinical Trials.
- Published in:
- Pharmaceutical Medicine, 2024, v. 38, n. 2, p. 133, doi. 10.1007/s40290-023-00512-9
- By:
- Publication type:
- Article
7
Physician Awareness of the Safe Use of Cyproterone Acetate in Europe: A Survey on the Effectiveness of Additional Risk Minimization Measures.
- Published in:
- Pharmaceutical Medicine, 2024, v. 38, n. 2, p. 145, doi. 10.1007/s40290-023-00510-x
- By:
- Publication type:
- Article
8
Potential of Artificial Intelligence to Accelerate Drug Development for Rare Diseases.
- Published in:
- Pharmaceutical Medicine, 2024, v. 38, n. 2, p. 79, doi. 10.1007/s40290-023-00504-9
- By:
- Publication type:
- Article